Content area

|
|

Hjertesvigtsbehandling til patienter med kronisk nedsat venstre ventrikel-funktion

Forfatter(e)
Hans Eiskjær Hjertesygdomme, Aarhus Universitetshospital

Ugeskr Læger 2018;180:V06180453
Reference: 
Ugeskr Læger 2018;180:V06180453
Blad nummer: 
Sidetal: 

Hans Eiskjær:

Treatment of heart failure in patients with reduced left-
ventricular ejection fraction

Ugeskr Læger 2018;180:V06180453

Treatment of heart failure with reduced ejection fraction has undergone an enormous development over the latest three decades resulting in lower mortality. Standard treatment now includes use of angiotensin-converting-enzyme (ACE)-inhibitors, beta blockers and mineralocorticoid receptor antagonists. Diuretics are still the cornerstone in the symptomatic treatment of fluid retention. Combined angiotensin II receptor blockade and neprilysin inhibition is a new treatment option instead of ACE-inhibition for selected patients. Cardiac resynchronisation therapy and prophylactic implantable cardiac defibrillators further reduce mortality.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Ulf Bern Jensen | 24/11
2 kommentarer
af Bodil Marie Nielsen | 24/11
2 kommentarer
af Jan Nielsen | 23/11
1 Kommentar
af Toke Seierøe Barfod | 23/11
2 kommentarer
af Thorkild I.A. Sørensen | 20/11
1 Kommentar
af Kim Varming | 20/11
1 Kommentar
af Niels Holmark Andersen | 20/11
1 Kommentar
af Jesper Brandt Andersen | 19/11
1 Kommentar
af Jens Anton Filtenborg | 16/11
1 Kommentar